Aug 9, 2022 7:53am
George Fritsma and guest speaker Brandon Michael Henry, MD, Investigative Pathologist at the Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, and Chair of the International Federation of Clinical Chemistry and Laboratory Medicine SARS-CoV-2 Variants Working Group, discuss COVID-19 pathophysiology, elucidating the mechanisms driving COVID-19 associated coagulopathy, immunopathology, and multi-organ injury in a three-part "Coag Conversation" sponsored by BioMedica Diagnostics, Inc.: What Have We Learned About Inflammation and Thrombosis Since the COVID-19 Outbreak?
Aug 4, 2022 1:54pm
Here is a breakthrough study from Tunisia indicating the efficacy of sulodexide [Aterina], the oral "fast-moving heparin"-dermatan sulfate formulation, in managing the endothelial dysfunction of and reducing the symptoms associated with Long Covid. Sulodexide is not FDA-approved for Long Covid therapy.
Aug 4, 2022 1:34pm
On Wednesday, 8-3-22, the ISTH published comprehensive guidelines recommending for or against antithrombotic agents for Covid at
Aug 1, 2022 5:50pm
Here's a link to our August 2022 Cheat Sheet, which will also appear in your inbox this week. It may contain a hint to this month's Quick Question.